Selling prescription drugs can be a pain. Doceree offers an easy way out
The pharma-marketing start-up has patented tech to reach the right message to the right doctor
Debangana Ghosh - November 04, 2020
New growth model
Indian pharma majors are facing their toughest year yet in the US, with regulatory clampdown, hostile political environment and falling prices. Is reinvention the answer to their woes?
Kripa Mahalingam - July 26, 2019
Tricky Transition
Generic Indian pharma players are changing their formula to focus on high-margin complex generics and specialty drugs
N Mahalakshmi - July 16, 2019
Art Underfoot
Make your home picture-perfect with these premium artistic rugs
Naini Thaker - April 06, 2018
Just what the doctor ordered
The Indian pharma industry has a stellar decadal run and it’s not going to change anytime soon
December 23, 2017
Nursing Back to Health
A strong product pipeline and receding US FDA threat could well turn the tide in favour of the beleaguered pharma players
Jash Kriplani - October 18, 2017
The Comeback Plan
Lupin is betting on its specialty drugs business to counter the pricing pressures in the US generics market
Khushboo Balani - October 03, 2017
Bold and Bountiful
Not content with the initial win in biosimiliars, Kiran Mazumdar-Shaw is pushing new frontiers in biologics
Kripa Mahalingam - July 11, 2017
A Bitter Pill
Regulatory woes continue to pile up for pharma companies
Kripa Mahalingam - May 12, 2017
Preserving the fabric
Impulse Social Enterprises is ensuring sustainable livelihoods in the northeast
Mahithi Pillay - July 24, 2015
